Leukemia, Myeloid, Acute

Showing NaN - NaN of 18

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Myeloid, Acute Trial in Canada, United States (VOR33, Mylotarg)

Recruiting
  • Leukemia, Myeloid, Acute
  • La Jolla, California
  • +8 more
Jan 31, 2023

Leukemia, Myeloid, Acute Trial in Worldwide (Oral Azacitidine, Placebo)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Oral Azacitidine
  • Placebo
  • Phoenix, Arizona
  • +247 more
Jan 13, 2023

Leukemia, Myeloid, Acute Trial in Worldwide (CC-90009, Venetoclax, Azacitidine)

Recruiting
  • Leukemia, Myeloid, Acute
  • San Francisco, California
  • +25 more
Jan 9, 2023

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

Recruiting
  • Leukemia
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +9 more
Sep 9, 2022

A Long-term Follow-up Study of Patients Who Received VOR33

Recruiting
  • Leukemia, Myeloid, Acute
  • VOR33
  • La Jolla, California
  • +7 more
Aug 9, 2022

Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))

Recruiting
  • Leukemia, Myeloid, Acute
  • +2 more
  • H3B-8800 (RVT-2001)
  • Stanford, California
  • +26 more
Mar 23, 2022

Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-95251, Azacitidine)

Recruiting
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • Marina Del Rey, California
  • +35 more
Mar 11, 2022

Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

Active, not recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Gilbert, Arizona
  • +23 more
Feb 22, 2022

Leukemia, Myeloid, Acute, AML Trial in United States (PTC299)

Terminated
  • Leukemia, Myeloid, Acute
  • AML
  • Aurora, Colorado
  • +16 more
Jan 18, 2022

Leukemia, Myeloid, Acute Trial in Worldwide (glasdegib, daunorubicin + cytarabine, azacitidine)

Completed
  • Leukemia, Myeloid, Acute
  • Los Angeles, California
  • +148 more
Jan 24, 2022

Connect® Myeloid Disease Registry

Recruiting
  • Primary Myelofibrosis
  • +2 more
    • Huntsville, Alabama
    • +228 more
    Mar 30, 2021

    Leukemia, Myeloid, Acute Trial in Australia, Korea, Republic of, United States (NLA101, Standard of Care (SOC) chemo)

    Terminated
    • Leukemia, Myeloid, Acute
    • NLA101
    • Standard of Care (SOC) chemotherapy
    • La Jolla, California
    • +35 more
    Mar 25, 2021

    Leukemia, Myeloid, Acute Trial in Worldwide (AC220)

    Completed
    • Leukemia, Myeloid, Acute
    • Los Angeles, California
    • +23 more
    Dec 20, 2019

    Leukemia, Myeloid, Acute Trial in Australia, Ireland, United States (GMI-1271, Mitoxantrone, Etoposide)

    Completed
    • Leukemia, Myeloid, Acute
    • Sacramento, California
    • +7 more
    May 13, 2019

    Leukemia, Myeloid, Acute Trial in United States (AC220)

    Completed
    • Leukemia, Myeloid, Acute
    • Duarte, California
    • +4 more
    Feb 8, 2019

    Leukemia, Myeloid, Acute, MDS Trial in United Kingdom, United States (CC-486)

    Completed
    • Leukemia, Myeloid, Acute
    • Myelodysplastic Syndromes
    • New York, New York
    • +4 more
    Oct 22, 2018

    Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma Trial in United States

    Completed
    • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
    • +5 more
    • Haploidentical Bone Marrow Transplantation
    • GVHD prophylaxis
    • Duarte, California
    • +16 more
    Nov 28, 2017

    Leukemia, Myeloid, Acute Trial in Australia, United States (CSL362)

    Completed
    • Leukemia, Myeloid, Acute
    • CSL362
    • Chicago, Illinois
    • +4 more
    Oct 8, 2015